Australia · Delayed Price · Currency is AUD Clarity Pharmaceuticals Statistics
Total Valuation
ASX:CU6 has a market cap or net worth of AUD 936.43 million. The enterprise value is 758.18 million.
| Market Cap | 936.43M |
| Enterprise Value | 758.18M |
Important Dates
The next estimated earnings date is Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:CU6 has 373.08 million shares outstanding. The number of shares has increased by 13.88% in one year.
| Current Share Class | 373.08M |
| Shares Outstanding | 373.08M |
| Shares Change (YoY) | +13.88% |
| Shares Change (QoQ) | +13.25% |
| Owned by Insiders (%) | 13.02% |
| Owned by Institutions (%) | 30.93% |
| Float | 292.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 88.96 |
| PB Ratio | 5.03 |
| P/TBV Ratio | 5.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 72.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.09
| Current Ratio | 16.09 |
| Quick Ratio | 15.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -77.54% and return on invested capital (ROIC) is -49.02%.
| Return on Equity (ROE) | -77.54% |
| Return on Assets (ROA) | -45.12% |
| Return on Invested Capital (ROIC) | -49.02% |
| Return on Capital Employed (ROCE) | -58.04% |
| Weighted Average Cost of Capital (WACC) | 10.76% |
| Revenue Per Employee | 105,263 |
| Profits Per Employee | -1.07M |
| Employee Count | 88 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:CU6 has paid 860,559 in taxes.
| Income Tax | 860,559 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.03% in the last 52 weeks. The beta is 1.18, so ASX:CU6's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -27.03% |
| 50-Day Moving Average | 2.39 |
| 200-Day Moving Average | 2.97 |
| Relative Strength Index (RSI) | 50.46 |
| Average Volume (20 Days) | 2,167,511 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CU6 had revenue of AUD 10.53 million and -107.24 million in losses. Loss per share was -0.29.
| Revenue | 10.53M |
| Gross Profit | 10.53M |
| Operating Income | -108.38M |
| Pretax Income | -106.28M |
| Net Income | -107.24M |
| EBITDA | -108.10M |
| EBIT | -108.38M |
| Loss Per Share | -0.29 |
Balance Sheet
The company has 178.25 million in cash and no debt, with a net cash position of 178.25 million or 0.48 per share.
| Cash & Cash Equivalents | 178.25M |
| Total Debt | n/a |
| Net Cash | 178.25M |
| Net Cash Per Share | 0.48 |
| Equity (Book Value) | 186.11M |
| Book Value Per Share | 0.50 |
| Working Capital | 186.15M |
Cash Flow
In the last 12 months, operating cash flow was -92.55 million and capital expenditures -306,922, giving a free cash flow of -92.85 million.
| Operating Cash Flow | -92.55M |
| Capital Expenditures | -306,922 |
| Depreciation & Amortization | 248,878 |
| Net Borrowing | n/a |
| Free Cash Flow | -92.85M |
| FCF Per Share | -0.25 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,029.61% |
| Pretax Margin | -1,009.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:CU6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.88% |
| Shareholder Yield | -13.88% |
| Earnings Yield | -11.45% |
| FCF Yield | -9.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for ASX:CU6 is 7.20, which is 186.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 7.20 |
| Price Target Difference | 186.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 86.89% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:CU6 has an Altman Z-Score of 55.9 and a Piotroski F-Score of 2.
| Altman Z-Score | 55.9 |
| Piotroski F-Score | 2 |